<DOC>
	<DOCNO>NCT01148147</DOCNO>
	<brief_summary>Aim study evaluate benefit adjunctive intracoronary administration adenosin elective patient undergo coronary angioplasty .</brief_summary>
	<brief_title>Intracoronary Adenosine Administration Prevent Periprocedural Myonecrosis Elective Coronary Angioplasty</brief_title>
	<detailed_description>This study investigate effect adjunctive intracoronary administration adenosine periprocedural myocardial infarction compare placebo . This double-blind randomized trial single-center study . The enrollment last 10 month .</detailed_description>
	<mesh_term>Adenosine</mesh_term>
	<criteria>Patients undergo elective coronary angioplasty Marked Bradycardia ( &lt; 40 bpm ) Previous allergy adenosine Inability sign inform consent Asthma Elevated cardiac enzyme ( troponin I CKMB )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>Adenosine</keyword>
	<keyword>randomize trial</keyword>
	<keyword>periprocedural myocardial necrosis</keyword>
	<keyword>elective coronary angioplasty</keyword>
</DOC>